Harvard Business Review

SEPTEMBER 12, 2012

Since companies test their own products—an obvious conflict of interest—they naturally design clinical trials to maximize evidence that they are beneficial and minimize evidence they are harmful. See The Risks of Prescription Drugs (Columbia 2010). These cost employers even more in hidden ways.

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

NOVEMBER 11, 2013

The Mayo Quality Academy offers 30 courses, ranging from Lean and Six-Sigma to Human Factors and Change Management. In addition to disclosing conflicts of interest, physicians attest to participating in the QIP and report their roles (see Table 2 ). Meaningful participation standards.

Quality 8

Quality Mayo System Six Sigma 8

Harvard Business Review

DECEMBER 6, 2012

For example, the SEC in 2010 had charged Goldman with misleading some of the parties to a billion dollar transaction (involving a complex derivative called a synthetic collateralized debt obligation), alleging specific facts about undisclosed conflicts of interest. Goldman settled within months for $550 million.

Conflict of Interest 8

Conflict of Interest CEO Asset Management Committee 8

Harvard Business Review

FEBRUARY 3, 2017

The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1% For instance, 60 institutional investors, collectively managing more than $5.5 For each $1 billion spent on R&D, the number of new medicines approved has halved roughly every nine years since 1950.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8

Harvard Business Review

MARCH 2, 2017

On February 3 President Trump issued an executive order directing the Treasury Department to conduct a sweeping review of financial regulation, including Dodd-Frank , the financial reform bill passed, in 2010, as part of the Obama administration’s response to the 2008 financial crisis and subsequent recession.

Banking 8

Banking Crisis System Compliance 8